Dexrazoxane hydrochloride is a cardioprotective agent. It was discovered by Kurt
Hellmann in 1972. Dexrazoxane is a sterile, pyrogen-free lyophilizate intended ...
Dexrazoxane injection is available as 2 different products that are used to treat or
prevent certain side effects that may be caused by chemotherapy medications.
Jul 2, 2013 ... On September 6, 2007, the FDA approved dexrazoxane hydrochloride for
injection (Totect™ made by TopoTarget USA, Inc.), equivalent to 500 ...
FDA Statement on Dexrazoxane. [07-20-2011]. The United States Food and Drug
Administration (FDA) is informing the public that on June 23, 2011, the ...
Jul 16, 2012 ... ZINECARD® (dexrazoxane for injection) is a sterile, pyrogen-free lyophilizate
intended for intravenous administration. It is a cardioprotective ...
Pictures of Zinecard (Dexrazoxane), drug imprint information, side effects for the
3 days ago ... Easy to read patient leaflet for dexrazoxane. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jun 13, 2005 ... Dexrazoxane, the (+)-enantiomorph of razoxane, provides cardioprotection
against anthracycline toxicity. It appears to inhibit formation of a ...
Dexrazoxane official prescribing information for healthcare professionals.
Includes: indications, dosage, adverse reactions, pharmacology and more.
Dexrazoxane is used to protect the heart and other tissues from harmful side
effects caused by certain cancer medications. The Zinecard brand of